TargetMol

Lysinenorleucine

Product Code:
 
TAR-T33069
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T33069-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33069-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33069-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Lysinenorleucine s a Lysine and hydroxylysine derivatives that can be used for the treatment of malignant and benign tumors.
CAS:
25612-46-8
Formula:
C12H25N3O4
Molecular Weight:
275.349
Purity:
0.98
SMILES:
N[C@@H](CCCCNCCCC[C@H](N)C(O)=O)C(O)=O

References

1. van den Nieuwendijk AM, Benningshof JC, Wegmann V, Bank RA, te Koppele JM, Brussee J, van der Gen A. Synthesis of reduced collagen crosslinks. Bioorg Med Chem Lett. 1999 Jun 21;9(12):1673-6. PubMed PMID: 10397498. 2. Nakamura Y, Okamoto K, Tanimura A, Kato M, Morimatsu M. Elastase digestion and biochemical analysis of the elastin from an elastofibroma. Cancer. 1986 Sep 1;58(5):1070-5. PubMed PMID: 3637115. 3. Nielsen CJ, Bentley JP, Marshall FJ. Age-related changes in reducible crosslinks of human dental pulp collagen. Arch Oral Biol. 1983;28(8):759-64. PubMed PMID: 6579908. 4. Liu Y, Springer IN, Zimmermann CE, A?il Y, Scholz-Arens K, Wiltfang J, Terheyden H. Missing osteogenic effect of expanded autogenous osteoblast-like cells in a minipig model of sinus augmentation with simultaneous dental implant installation. Clin Oral Implants Res. 2008 May;19(5):497-504. doi: 10.1111/j.1600-0501.2007.01504.x. Epub 2008 Mar 26. PubMed PMID: 18371097.